共 141 条
[1]
Przydacz M(2017)What do we know about neurogenic bladder prevalence and management in developing countries and emerging regions of the world? Ann Phys Rehabil Med 60 341-346
[2]
Denys P(2021)Validity of the urinary symptom questionnaires for people with neurogenic bladder (USQNB) who void or use indwelling catheters Spinal Cord 59 948-958
[3]
Corcos J(2011)Epidemiology and healthcare utilization of neurogenic bladder patients in a US claims database Neurourol Urodyn 30 395-401
[4]
Tractenberg RE(2021)How to treat neurogenic bladder and sexual dysfunction after spinal cord lesion Rev Neurol 177 589-593
[5]
Frost JK(2015)Screening for depression and anxiety in childhood neurogenic bladder dysfunction J Pediatr Urol 11 75.e71-75.e77
[6]
Yumoto F(2013)The epidemiology and pathophysiology of neurogenic bladder Am J Manag Care 19 s191-s196
[7]
Rounds AK(2015)The worldwide economic impact of neurogenic bladder Curr Bladder Dysfunct Rep 10 350-354
[8]
Ljungberg IH(2021)The efficacy and safety of mirabegron for the treatment of neurogenic lower urinary tract dysfunction: a systematic review and meta-analysis Front Pharmacol 12 756582-11
[9]
Groah SL(2021)Chinese medicine therapies for neurogenic bladder after spinal cord injury: a protocol for systematic review and network meta-analysis Medicine 100 e27215-226
[10]
Manack A(2012)Developing core outcome sets for clinical trials: issues to consider Trials 13 132-undefined